ADMA Biologics Inc vs American Express Co — how do they compare? ADMA Biologics Inc trades at $9.81 (market cap $2.22B), while American Express Co trades at $340.05 (market cap $230.15B). The key difference: American Express Co is far larger — about 103.7× ADMA Biologics Inc's market cap, and American Express Co pays a 1.11% dividend while ADMA Biologics Inc pays none. Which is the better fit depends on your goals.
| ADMA | AXP | |
|---|---|---|
Market Cap | $2.22B | $230.15B |
Sector | Health | Financials |
52-Week High | $20.38 | $384.82 |
52-Week Low | $7.60 | $292.27 |
Enterprise Value | $2.29B | — |
Dividend Yield | — | 1.11% |
Trailing returns across standard periods
Latest headlines on both assets
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →American Express Company is a global payment and travel company. The Company's principal products and services are charge and credit payment card products and travel-related services offered to consumers and businesses around the world.
Read more on AXP →